These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1804058)

  • 21. Pyridine-substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluation.
    Ertas M; Sahin Z; Berk B; Yurttas L; Biltekin SN; Demirayak S
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700272. PubMed ID: 29522642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation.
    Saberi MR; Vinh TK; Yee SW; Griffiths BJ; Evans PJ; Simons C
    J Med Chem; 2006 Feb; 49(3):1016-22. PubMed ID: 16451067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and aromatase inhibitory activity of novel pyridine-containing isoflavones.
    Kim YW; Hackett JC; Brueggemeier RW
    J Med Chem; 2004 Jul; 47(16):4032-40. PubMed ID: 15267241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modification of enzymatic activity and difference spectra of cytochrome P-450 from various sources by cholesterol side chain cleavage inhibitors.
    Graves PE; Uzgiris VI; Salhanick HA
    Steroids; 1980 May; 35(5):543-59. PubMed ID: 6893091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and synthesis of a new type of non steroidal human aromatase inhibitors.
    Sonnet P; Guillon J; Enguehard C; Dallemagne P; Bureau R; Rault S Auvray P; Moslemi S; Sourdiane P; Galopin S; Séralini GE
    Bioorg Med Chem Lett; 1998 May; 8(9):1041-4. PubMed ID: 9871704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel activity for a group of sesquiterpene lactones: inhibition of aromatase.
    Blanco JG; Gil RR; Alvarez CI; Patrito LC; Genti-Raimondi S; Flury A
    FEBS Lett; 1997 Jun; 409(3):396-400. PubMed ID: 9224697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformational analysis of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione (rogletimide) and discovery of potent 5-alkyl derivatives.
    McCague R; Rowlands MG
    J Med Chem; 1992 Oct; 35(20):3699-704. PubMed ID: 1433182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of novel pyrrolidine-2,5-dione inhibitors as potential anti-tumour agents.
    Ahmed S; Smith JH; Nicholls PJ; Whomsley R; Cariuk P
    Drug Des Discov; 1995 Apr; 12(4):275-87. PubMed ID: 9040988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline.
    Kellis JT; Vickery LE
    Endocrinology; 1984 Jun; 114(6):2128-37. PubMed ID: 6723577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cholesterol side chain cleavage inhibitors on 11 beta-hydroxylation: linkage of mitochondrial oxygenase systems.
    Whipple CA; Grodzicki RL; Hourihan J; Salhanick HA
    Steroids; 1981 Jun; 37(6):673-9. PubMed ID: 6974914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and aromatase inhibitory activity of some new 16E-arylidenosteroids.
    Bansal R; Thota S; Karkra N; Minu M; Zimmer C; Hartmann RW
    Bioorg Chem; 2012 Dec; 45():36-40. PubMed ID: 23064126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and aromatase inhibitory activity of flavanones.
    Pouget C; Fagnere C; Basly JP; Besson AE; Champavier Y; Habrioux G; Chulia AJ
    Pharm Res; 2002 Mar; 19(3):286-91. PubMed ID: 11934235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
    Santen RJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Org 33201: a new highly selective orally active aromatase inhibitor.
    Geelen JA; Loozen HJ; Deckers GH; de Leeuw R; Kloosterboer HJ; Lamberts SW
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):681-2. PubMed ID: 8476784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and evaluation of 4-substituted-4-androstene-3,17-dione derivatives as aromatase inhibitors.
    Abul-Hajj YJ; Liu XP; Hedge M
    J Steroid Biochem Mol Biol; 1995 Aug; 54(3-4):111-9. PubMed ID: 7662584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imidazole derivatives of pyrrolidonic and piperidonic as potential inhibitors of human placental aromatase in vitro.
    Baroudi M; Robert J; Luu-Duc C
    J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):73-7. PubMed ID: 8645619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of benzimidazole and imidazole compounds as potential aromatase inhibitors.
    Hida F; Robert J; Luu-Duc C
    Farmaco; 1994; 49(7-8):489-92. PubMed ID: 7945714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New aromatase inhibitors from the 3-pyridyl arylether and 1-aryl pyrrolo[2,3-c]pyridine series.
    Stauffer F; Furet P; Floersheimer A; Lang M
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1860-3. PubMed ID: 22335894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and aromatase inhibiting activity of aminoglutethimide analogs.
    Aboul-Enein HY
    Drug Des Deliv; 1988 Feb; 2(3):221-6. PubMed ID: 3255316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical use of aromatase inhibitors in human breast carcinoma.
    Santen RJ
    J Steroid Biochem Mol Biol; 1991; 40(1-3):247-53. PubMed ID: 1835644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.